Khartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops oral small molecule therapies for immunological and chronic diseases
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Develops inhaled therapies for severe respiratory diseases